Oyster Point Pharma Finds $22M For Dry Eye Treatment

San Francisco-based Oyster Point Pharmaceuticals, a startup developing therapies for treating “dry eye” and other ocular diseases, said this week that it has raised $22M in a funding round. The funding was led by Versant Ventures and New Enterprise Associates (NEA)…. (more) READ MORE>>

Read full post on silicontap.com

Leave a Reply

Your email address will not be published. Required fields are marked *